Genetic aspects of birth defects: New understandings of old problems

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 92, Issue 4, 2007, Pages

  Prescott, Katrina R ^b   Wilkie, Andrew O M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHOLINE DERIVATIVE;

BIRTH DEFECT; CHROMOSOME 22Q; DEVELOPMENTAL BIOLOGY; DIAGNOSTIC ACCURACY; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HUMAN; MOLECULAR IMPRINTING; MOSAICISM; PATHOPHYSIOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RNA INTERFERENCE; SYSTEMATIC REVIEW;

ABNORMALITIES; ABNORMALITIES, MULTIPLE; CHROMOSOME ABERRATIONS; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; HUMANS; INFANT, NEWBORN; MOSAICISM; MUTATION; NEOPLASMS; SYNDROME;

EID: 34347338747     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2004.062968     Document Type: Review

References (27)

1. Hickman-Davis JM, Davis IC. Transgenic mice. Paediatr Respir Rev 2006;7:49-53.
2. Downward J. RNA interference. BMJ 2004;328:1245-8.
3. Badano JL, Mitsuma N, Beales PL, et al. The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet 2006;22:125-48.
4. McKusick V and Johns Hopkins University. Online Mendelian Inheritance in Man (OMIM), 2007. Available at: http://www.ncbi.nlm.nih.gov/ entrez.
5. Epstein CJ, Erickson RP, Wynshaw-Boris A, eds. Inborn errors of development. New York, NY: Oxford University Press, 2004.
6. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997;34:798-804.
7. Baldini A. Dissecting contiguous gene detects: TBX1. Curr Opin Genet Dev 2005;15:279-84.
8. Ensenauer RE, Adeyinka A, Flynn HC, et al. Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients, Am J Hum Genet 2003;73:1027-40.
9. Tassabehji M. Williams-Beuren syndrome: a challenge for genotype-phenotype correlations. Hum Mol Genet 2003;12(Spec No 2):R229-37.
10. Tassabehji M, Hammond P, Karmiloff-Smith A, et al. GTF2IRD1 in craniofacial development of humans and mice. Science 2005;310:1184-7.
11. Somerville MJ, Mervis CB, Young EJ, et al. Severe expressive-language delay related to duplication of the Williams-Beuren locus. N Engl J Med 2005;353:1694-701.
12. Vissers LE, Veltman JA, van Kessel AG, et al. Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 2005;14(Spec No. 2):R215-R223.
13. Vissers LE, van Ravenswaaij CM, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004;36:955-7.
14. Horsthemke B, Buiting K. Imprinting defects on human chromosome 15. Cytogenet Genome Res 2006;113:292-9.
15. Eggermann T, Wollmann HA, Kuner R, et al. Molecular studies in 37 Silver-Russell syndrome patients: frequency and etiology of uniparental disomy. Hum Genet 1997;100:415-9.
16. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005;37:1003-7.
17. Maher ER, Brueton LA, Bowdin SC, et al. Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet 2003;40:62-4.
18. Wilkie AOM. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 2005;16:187-203.
19. Gelb BD, Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase transduction. Hum Mol Genet 2006;15(Spec No 2):R220-6.
20. Roberts A, Allanson J, Jadico SK, et al. The cardio-facio-cutaneous (CFC) syndrome: a review. J Med Genet 2006;43:833-42.
21. Cole WG, Dalgleish R. Perinatal lethal osteogenesis imperfecta. J Med Genet 1995;32:284-9.
22. Goriely A, McVean GA, Rojmyr M, et al. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 2003;301:643-6.
23. Twigg SRF, Kan R, Babbs C, et al. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci U S A 2004;101:8652-7.
24. Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003;22:183-98.
25. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005;37:19-24.
26. Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 2005;16:441- 67.
27. Arron JR, Winslow MM, Polleri A, et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006;441:595-600.